Pathobiology of the microRNA system;Pathobiologie des microRNA-Systems

Pathologe

Volumn 33, Issue 1, 2012, Pages 70-78

  Hussein, K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

MicroRNA; MicroRNA mRNA interaction; Pathobiology; RNAi; SiRNA

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN; SMALL INTERFERING RNA; UNTRANSLATED RNA;

ARTICLE; CELL TRANSFORMATION; EXOSOME; GENE EXPRESSION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; NEOPLASM; THROMBOCYTE; VIRUS CELL TRANSFORMATION;

BLOOD PLATELETS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EXOSOMES; GENE EXPRESSION; HUMANS; INFLAMMATION; MICRORNAS; NEOPLASMS; PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, UNTRANSLATED;

EID: 84857654434     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-011-1469-4     Document Type: Article

References (45)

1. Ahluwalia JK, Hariharan M, Bargaje R et al (2009) Incomplete penetrance and variable expressivity: is there a microRNA connection? Bioessays 31:981-992
2. Agirre X, Jiménez-Velasco A, San José-Enériz E (2008) Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-me-diated cell growth. Mol Cancer Res 6:1830-1840
3. Arasu P, Wightman B, Ruvkun G (1991) Temporal regulation of lin-14 by the antagonistic action of two other heterochronic genes, lin-4 and lin-28. Genes Dev 5:1825-1833 (Pubitemid 21905877)
4. Arroyo JD, Chevillet JR, Kroh EM et al (2011) Argo-naute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003-5008
5. Boultwood J, Pellagatti A, Cattan H et al (2007) Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. Br J Haematol 139:578-589 (Pubitemid 350043812)
6. Bousquet M, Quelen C, Rosati R et al (2008) Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t (2;11) (p21 ;q23) translocation. J Exp Med 205:2499-2506
7. Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467:415-419
8. Cimmino A, Calin GA, Fabbri M et al (2006) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944-13949 Erratum in: Proc Natl Acad Sci U S A103:2464
9. Cortez MA, Ivan C, Zhou P et al (2010) microRNAs in cancer: from bench to bedside. Adv Cancer Res 108:113-157
10. Dahiya N, Morin PJ (2010) MicroRNAs in ovarian carcinomas. Endocr Relat Cancer 17:F77-F89
11. Dhahbi JM, Atamna H, Boffelli D et al (2011) Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS One 6:e20509
12. Fabbri M, Croce CM, Calin GA (2009) MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 50:160-170
13. Farazi TA, Horlings HM, Ten Hoeve J et al (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71:4443-4453
14. Fendler A, Stephan C, Yousef GM, Jung K (2011 ) MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 57:954-968
15. Fu X, Han Y, Wu Y et al (2011) Prognostic role of mi-croRNA-21 in various carcinomas: a systematic re-viewand meta-analysis. Eur J Clin Invest41:1245-1253
16. Gupta SK, Bang C, Thum T (2010) Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardio-vasc Genet 3:484-488
17. Hasemeier B, Christgen M, Kreipe H, Lehmann U (2008) Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol 8:90
18. Hong L, Han Y, Li S et al (2010) The malignant phe-notype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin BiolTher 10:1693-1701
19. Hussein K, Büsche G, Muth M et al (2011 ) Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia. Ann Hematol 90:307-313
20. Hussein K, Theophile K, Büsche G et al (2010) Aberrant microRNA expression pattern in myelody-splastic bone marrow cells. Leuk Res 34:1169-1174
21. Hussein K, Theophile K, Dralle W et al (2009) MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocyt-hemia. Platelets 20:391-400
22. Jazbutyte V, Thum T (2010) MicroRNA-21:from cancer to cardiovascular disease. Curr Drug Targets 11:926-935
23. Kontorovich T, Levy A, Korostishevsky M et al (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589-597
24. Kozomara A, Griffiths-Jones S (2011) iRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157
25. Lee RC, Feinbaum RL, Ambros V (1993) The C. ele-gans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854 (Pubitemid 24014542)
26. Lehmann U, Hasemeier B, Christ gen M et al (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17-24
27. Li J, Smyth P, Flavin R et al (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7:36
28. Lin PY, Yu SL, Yang PC (2010) MicroRNA in lung cancer. Br J Cancer 103:1144-1148
29. Lorenzen JM, Haller H, Thum T (2010) MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7:286-294
30. Napoli C, Lemieux C, Jorgensen R (1990) Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2:279-289 (Pubitemid 120029588)
31. Mesri EA, Cesarman E, Boshoff C (2011) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10:707-719
32. Mueller DW, Bosserhoff AK (2010) The evolving concept of 'melano-miRs'-microRNAs in melano-magenesis. Pigment Cell Melanoma Res 23:620-626
33. Osman A, Fälker K (2011) Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 22:433-441
34. Pallante P, Visone R, Croce CM, Fusco A (2010) Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17:F91-F104
35. Potapova A, Albat C, Hasemeier B et al (2011) Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution. BMC Biotechnol 11:6
36. Purow B (2010) The elephant in the room: do mi-croRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? J Neurooncol 103:429-436
37. Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906 (Pubitemid 30130993)
38. Schetter AJ, Leung SY, Sohn JJ et al (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436 (Pubitemid 351185951)
39. Starczynowski DT, Kuchenbauer F, Argiropoulos B et al (2010) Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenoty-pe. Nat Med 16:49-58
40. Krol AR van der, Mur LA, Lange P de et al (1990) Inhibition of flower pigmentation by antisense CHS genes: promoter and minimal sequence requirements for the antisense effect. Plant Mol Biol 14:457-466
41. Venturini L, Battmer K, Castoldi M et al (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109:4399-4405 (Pubitemid 46743409)
42. Votavova H, Grmanova M, Dostalova Merkerova M (2011) Differential expression of microRNAs in CD34+ cells of 5q- syndrome. J Hematol Oncol 4:1
43. Wu BH, Xiong XP, Jia J, Zhang WF (2011) MicroRNAs: New actors in the oral cancer scene. Oral Oncol 47:314-319
44. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730-755
45. Zhang Y, Liu D, Chen X et al (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39:133-144